Sarepta Therapeutics Balance Sheet - Quarterly (NASDAQ:SRPT)

Add to My Stocks
$32.02 $1.87 (6.2%) SRPT stock closing price Feb 24, 2017 (Closing)

The Sarepta Therapeutics balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Sarepta Therapeutics stock analysis, and provides insights into the firm's financial performance. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The Sarepta Therapeutics balance sheet for 2016-Q3 shows cash on hand of $395.14M. View Sarepta Therapeutics quarterly results to get the balance sheet details for the latest & last 40 quarters data..

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1
Marketable Securities10.69M101.85M122.88M44.09M87.34M91.78M136.79M187.71M180.78M183.34M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets22M16.88M17.38M19.46M23.09M24.41M35.03M26.43M15.9M9.07M
Sarepta Therapeutics Total Current Assets
Property Plant & Equipment64.04M62.8M61.93M60.74M59.38M58.79M58.39M56.04M38.1M37.23M
Accumulated Depreciation28.42M25.82M24.59M23.36M22.19M21.03M19.89M18.86M17.94M17.1M
Sarepta Therapeutics Net Property Plant & Equipment
Investment & Advances0.78M0.78M0.78M11.47M0.78M0.78M0.78M0.64M0.64M0.64M
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets8.05M8.14M4.47M7.67M5.31M5.27M2.06M5.72M6.44M0.02M
Sarepta Therapeutics Total Assets
Notes Payable2.49M---------
Accounts Payable20.68M18.67M20.23M7.43M14.09M9.31M12.4M0.96M1.3M7.72M
Current Portion Long-Term Debt10.1M7.6M5.93M3.43M0.1M0.09M0.09M0.09M0.09M0.09M
Current Portion Capital Leases----------
Accrued Expenses29.53M24.27M29.05M19.76M15.18M15.03M17.36M14.82M13.83M16.34M
Income Taxes Payable----------
Other Current Liabilities4.6M4.6M4.57M4.58M4.67M4.61M4.5M4.42M14.16M13.6M
Sarepta Therapeutics Total Current Liabilities
Deferred Taxes/Income5.26M5.86M6.17M6.45M6.72M6.59M6.77M6.36M6.45M7.11M
Convertible Debt----------
Long-Term Debt8.49M13.37M14.96M17.39M20.65M1.45M3.73M3.76M1.52M1.55M
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Sarepta Therapeutics Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net0.01M0.01M0.01M-------
Capital Surplus1.49B1.1B1.09B957.6M947.82M941.35M926.76M920.86M905.33M800.52M
Retained Earnings-1.08B-958.82M-899.05M-834.37M-782.43M-740.58M-679.02M-634.6M-605.38M-571.5M
Treasury Stock----------
Other Liabilities--0.01M-0.11M--0.01M-0.01M-0.09M-0.05M-0.03M-0.05M
Sarepta Therapeutics Shareholders Equity
Sarepta Therapeutics Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Balance sheet for another ticker

Apart from balance sheet items, an investor would do well to keep track of the Sarepta Therapeutics stock price by looking at Sarepta Therapeutics historical stock prices. One can compare PE with industry average by looking at the Sarepta Therapeutics PE ratio chart. The common balance sheet items are:
  • Assets: An asset is a resource that a corporation like Sarepta Therapeutics owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for SRPT stock as of quarter is $487.31M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Sarepta Therapeutics's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for SRPT stock stand at $78.68M.

Sarepta Therapeutics Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio

Quarterly Balance Sheets For Sarepta Therapeutics Inc Peers

Aviragen Therapeutics balance sheet, AveXis balance sheet, BioCryst Pharma balance sheet, Gilead Sciences balance sheet, Halozyme Therapeutics balance sheet